Funtleyder on Lilly's Alzheimer's Drug

Oct. 9 (Bloomberg) -- Les Funtleyder, president of the investment advisory division at Poliwogg, talks about Eli Lilly & Co.'s experimental Alzheimer's treatment, the Alzheimer's drug market and the outlook for Lilly and PDL BioPharma Inc. He speaks with Pimm Fox on Bloomberg Television's "Taking Stock." Bloomberg's Shannon Pettypiece also speaks. (Source: Bloomberg)
Will Oil Retest Lows: Surveillance (Full Show 07/28)
47:11 - Full episode of “Bloomberg Surveillance.” Guests include Renaissance Macro Research U.S. Economics Research Head Neil Dutta, Oppenheimer & Co. Senior Analyst Fadel Gheit and Canaccord Genuity's Tony Dwyer. (Source: Bloomberg)
  • 20 U.S. Cities See Slower Rise in Home Prices
  • It's a Market of Stocks, Not a Stock Market: Borish
  • Ford Drives Fully-Loaded F-150 Sales to 44% Profit Growth